Navigation Links
Site-Specific Drug Delivery Market, By Application (Pulmonary, Ocular, Oncology, CNS, Cardiovascular) - World Forecasts to 2022
Date:1/3/2017

LONDON, Jan. 3, 2017 /PRNewswire/ -- The advent of site specific/targeted drug delivery has revolutionized the drug delivery industry. This technique is allowing a previously unattainable level of drug delivery with greater efficiency to target organs and tissues. Due to this ability, the share of site specific drug delivery is incessantly increasing in the drug delivery industry. It is anticipated that the global site specific drug delivery market will cross US$ 114 Billion by 2022. The growth of the market is likely to be driven by expanding drug discovery applications, rising chronic disease incidences, and increasing research related activities for exploring drug delivery therapeutic applications.

The report, "Site-Specific Drug Delivery Market, By Application (Pulmonary, Ocular, Oncology, CNS, Cardiovascular) - World Forecasts to 2022", provides an insight into the current and future prospective of this market. This report covers the major opportunities in this area, and drivers that have impact on the market. The report also discusses some of the challenges currently faced by the market.

The major application areas of targeted drug delivery pulmonary, ocular, oncology, and others including CNS, cardiovascular, etc. Oncology based application is the largest area of application of targeted drug delivery. This large share can be attributed to various research related activities conducted for developing targeted drug delivery approach for cancer.

Moreover, the report also contains the market share of major regions, including North America, Europe, and Asia Pacific. North America holds the largest market share, while Asia Pacific is expected to witness highest growth in the coming years, i.e. 2016-2022. The major reasons for the high growth are the ongoing researches in China and Australia, which is expanding therapeutic applications of site specific drug delivery to brain disorders. North America and Europe are expected to grow at a modest rate due to less stringent regulatory approval process and advancements in drug delivery technique.

The last segment of the report is entirely devoted to profiling leading companies of the targeted drug delivery industry, including some major players like Celgene Corporation, Arrowhead Pharma, Intezyne, Endocyte, BioDelivery Sciences International, PharmaIN, Mirus Bio, Savara, etc. This segment provides access to the financials, product portfolio, and recent developments of these companies. This segment also discusses the strengths and weaknesses of key players in this industry. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the global site specific drug delivery market.

Download the full report: https://www.reportbuyer.com/product/4491939/

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com
 
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/site-specific-drug-delivery-market-by-application-pulmonary-ocular-oncology-cns-cardiovascular---world-forecasts-to-2022-300385083.html


'/>"/>
SOURCE ReportBuyer
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Drug and Gene Delivery Systems Market Worth $786.9 Billion by 2025: Grand View Research, Inc.
2. Research and Markets - Insulin Delivery Devices Market to Reach $19 Billion by 2025 - Key Vendors are Novo Nordisk, Sanofi & Biocon
3. Pulmatrix Receives Patents Important to its Inhaled Drug Delivery Technology
4. Animal Antibiotics and Antimicrobials Market by Product, Mode of Delivery, Animal - Global Forecast to 2021 -- Research and Markets
5. Transdermal Drug Delivery System - Global Market Outlook (2016-2022)
6. Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
7. Global Drug Delivery in Cancer Technologies, Markets and Companies Report 2016-2025: Profiles of 200+ Companies & 250+ Collaborations - Research and Markets
8. United States Lancet and Lancing Devices Market Report 2016-2017 with Diabetes Monitoring, Treatment And Drug Delivery Market Overview - Research and Markets
9. Emerus Continues Focus On Innovation In Healthcare Delivery With Adoption Of VeinViewer Technology
10. New Review of Novel Intranasal Delivery of Sumatriptan as a Route to Rapid and Sustained Relief in the Acute Treatment of Migraine
11. Global Transdermal Drug Delivery Report 2016: Technologies, Markets, and Companies Analysis & Forecasts to 2025 - Research and Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2019)... ... June 19, 2019 , ... ... in vitro toxicology testing solutions, announced the addition of the Human MDR-1 ... existing in vitro toxicology offerings and allows researchers to perform critical toxicology testing ...
(Date:6/18/2019)... , ... June 18, 2019 , ... ... new facilities at 11500 W Olympic Blvd Suite 350 Los Angeles, CA, 90064, ... through research-backed methodologies. , MY Education Guru has created individual programs to ...
(Date:6/18/2019)... Tenn. (PRWEB) , ... June 18, 2019 , ... ... leader in emergency medicine and hospital medicine management services, are pleased to announce ... company based in Longview, Texas. , LEMA’s 34 physicians and 9 advanced ...
Breaking Medicine Technology:
(Date:6/19/2019)... ... ... CEO Steven C. Bilt of Smile Brands Inc. has won a Glassdoor Employees’ ... one of the world’s largest job and recruiting sites, released its annual report recognizing ... North America and parts of Europe. , Smile Brands, a leading dental support organization ...
(Date:6/19/2019)... ... June 19, 2019 , ... LifeLearn Animal Health launches ... pet insurance is, what it isn’t, and the questions they need to ask prior ... from different pet insurance companies and find the coverage that meets their budget and ...
(Date:6/18/2019)... ... June 18, 2019 , ... NeoTract, a wholly owned subsidiary ... urology, today announced that Aaron Berger, MD, Associated Urological Specialists, LLC in Chicago ... that Dr. Aaron Berger has achieved a high level of training and experience ...
(Date:6/16/2019)... ... June 16, 2019 , ... Ted Danson on CNBC ... research for the advancement of medical marijuana-based pharmaceuticals in an upcoming episode, scheduled ... more information. , With two investigational new drug applications already accepted by the ...
(Date:6/13/2019)... ... June 13, 2019 , ... MMJ BioPharma Cultivation, ... signed a memorandum of understanding (MOU) with MMJ International Holdings to grow cannabis ... , MMJ BioPharma Cultivation will be supplying MMJIH with extracts from the marijuana ...
Breaking Medicine News(10 mins):